After 5 Years Cervical Cancer Vaccine Tested in Brazil and US Keeps Working

    Young woman gets a cervical cancer vaccine shot

    Young woman gets a cervical cancer vaccine shot As the first FDA-approved cancer vaccine, designed to protect against human papillomavirus, has moved from scientific discussion to social debate, other vaccine studies are continuing to make progress. While HPV vaccine efforts had the "benefit" of a viral source for the disease, other researchers are developing vaccines for cancers that are not virally based, in an effort to coax the immune system into attacking cancerous cells.

    Today at the 2007 Annual Meeting of the American Association for Cancer Research, presentations on ongoing HPV trials and other new approaches to stimulating the immune system are injecting momentum into cancer vaccine research.

    Ongoing evaluation of a phase II trial of a human papillomavirus vaccine, developed to prevent cervical cancer, shows that the vaccine continues to protect against HPV types 16 and 18 at five and a half years into the study, according to researchers from the University of Louisville. Their findings also show that the vaccine offers significant cross-protection for HPV types 45 and 31.

    The study follows 1113 women between the ages of 15 and 25 in North America and Brazil randomized to receive three doses of either the vaccine or the control. The vaccine, made by GlaxoSmithKline, which funded the study, is designed to protect against two strains of HPV, types 16 and 18, which together are thought to cause nearly 72 percent of all cases of cervical cancer.

    At over five years into the study’s follow-up, the researchers found that approximately 98 percent of subjects still maintained protection against HPV types 16 and 18. Regardless of HPV status, the vaccine also appears to prevent most occurrences of cervical intraepithelial neoplasia lesions – abnormal, precancerous cell growths found in the cervix.

    They also found that the vaccination offered significant protection against genetically similar viruses. They determined the vaccine to be 88 percent effective against HPV type 45 and 54 percent effective against HPV type 31.

    "Overall, it is not a surprise that the vaccine offers protection against additional types of human papillomavirus, as they are all related genetically," said Stanley Gall, M.D., professor at the University of Louisville. "However, as you get genetically farther from types 16 and 18, you would expect to see less cross-protection."

    According to Dr. Gall, effective preventative treatment with the vaccine will depend on the long-term and broad protection the vaccine can offer against cancer-causing HPV types.

    Tags:

    • Show Comments (0)

    Your email address will not be published. Required fields are marked *

    comment *

    • name *

    • email *

    • website *

    This site uses Akismet to reduce spam. Learn how your comment data is processed.

    Ads

    You May Also Like

    Brazil Vows Better Pay for Teachers

    The Brazilian government will invest more resources on education. According to the Minister of ...

    Decision in Second Round, says headline

    Brazil’s Lula Pays the Penalty for Complacency

    President Luiz Inácio Lula da Silva’s failure to win the election in the first ...

    90% of Amazon Timber Is Illegal and Brazil Buys Most of It

    Ninety percent of all the timber currently produced in the Amazon is of illegal ...

    Brazil’s Petrobras Promises New Production Record

    The president of Brazil’s Petrobras, José Eduardo Dutra, guaranteed, March 16, that in April ...

    Boeing 737 crashed in the Brazilian Amazon

    Boeing Tragedy: Nobody Wins When US’s Xenophobia Crashes with Brazil’s Lunacy

    The tragedy involving the Legacy jet and the Boeing 737 over the Brazilian Amazon ...

    Ethanol from Brazil

    Brazil’s Copersucar Forecasts a US$ 5 Billion Sugarcane Crop

    Brazil's sugar industry giant Copersucar, a cooperative that operates in the trade of sugar ...

    Greek Entrepreneurs Open Shoe Factory in Brazil

    Up to the end of this month, a Greek shoe factory will start operating ...

    Death to Brazil’s Varig!

    In Brazil, only a foolish traveler flies Varig; or those fuming patriots, who insist ...

    All I Need to Feel at Home in Brazil Is a Face Overhaul

    Here in Brazil, I see so many natural looking, attractive, fit people. So, I ...

    TAM Brazil

    TAM’s New Direct Rio-New York Flight Arrives 6 am at JFK

    Brazilian airline TAM has started operating direct flights between Rio de Janeiro and New ...